Joint Stock Price, News & Analysis (NASDAQ:JYNT) $9.26 +0.47 (+5.35%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$8.76▼$9.2850-Day Range$7.37▼$9.3252-Week Range$7.31▼$20.00Volume137,036 shsAverage Volume159,116 shsMarket Capitalization$136.59 millionP/E Ratio71.24Dividend YieldN/APrice Target$21.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Joint MarketRank™ Stock AnalysisAnalyst RatingHold2.25 Rating ScoreUpside/Downside126.8% Upside$21.00 Price TargetShort InterestBearish4.75% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.91Based on 5 Articles This WeekInsider TradingAcquiring Shares$1.06 M Bought Last QuarterProj. Earnings Growth100.00%From $0.12 to $0.24 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.69 out of 5 starsMedical Sector84th out of 957 stocksPatent Owners & Lessors Industry1st out of 5 stocks 3.1 Analyst's Opinion Consensus RatingJoint has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.00, Joint has a forecasted upside of 126.8% from its current price of $9.26.Amount of Analyst CoverageJoint has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.75% of the outstanding shares of Joint have been sold short.Short Interest Ratio / Days to CoverJoint has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in Joint has recently increased by 18.86%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldJoint does not currently pay a dividend.Dividend GrowthJoint does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for JYNT. Previous Next 3.3 News and Social Media Coverage News SentimentJoint has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Joint this week, compared to 2 articles on an average week.Search Interest3 people have searched for JYNT on MarketBeat in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Joint insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,063,885.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 4.00% of the stock of Joint is held by insiders.Percentage Held by Institutions87.61% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Joint are expected to grow by 100.00% in the coming year, from $0.12 to $0.24 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Joint is 71.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 105.73.Price to Earnings Ratio vs. SectorThe P/E ratio of Joint is 71.24, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.68.Price to Book Value per Share RatioJoint has a P/B Ratio of 3.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Joint Stock (NASDAQ:JYNT)The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.Read More JYNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart JYNT Stock News HeadlinesDecember 1, 2023 | americanbankingnews.comJoint (NASDAQ:JYNT) Share Price Passes Above 50 Day Moving Average of $8.46November 30, 2023 | finance.yahoo.comThe Joint Chiropractic is Named a Proud Partner of the St. Louis BluesDecember 3, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 29, 2023 | finance.yahoo.comThe Joint Corp.'s (NASDAQ:JYNT) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?November 15, 2023 | finance.yahoo.comIs There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?November 13, 2023 | finance.yahoo.comThe Joint Chiropractic Announces its "Back Friday" DealNovember 12, 2023 | markets.businessinsider.comHold Rating on JYNT Amid Mixed 3Q23 Earnings and Strategic Repositioning UncertaintiesNovember 10, 2023 | finance.yahoo.comThe Joint Corp. (NASDAQ:JYNT) Q3 2023 Earnings Call TranscriptDecember 3, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 9, 2023 | seekingalpha.comJoint GAAP EPS of -$0.05, revenue of $29.5MNovember 9, 2023 | benzinga.comRecap: Joint Q3 EarningsNovember 9, 2023 | finance.yahoo.comThe Joint Corp. Reports Third Quarter 2023 Financial ResultsNovember 8, 2023 | finance.yahoo.comThe Joint Corp. Welcomes Jeff Gramm to the Board of Directors and Signs Standstill Agreement with Bandera Partners LLCNovember 7, 2023 | msn.comWWE NXT is moving to the CW Network in 2024October 26, 2023 | finance.yahoo.comThe Joint Corp. to Host Conference Call on Thursday, November 9th to Discuss Third Quarter 2023 ResultsOctober 18, 2023 | msn.comThe Joint Corp.'s Q2 Was Not As Gloomy As It SeemsOctober 18, 2023 | finance.yahoo.comThe Joint Chiropractic Jumps 30 Spots, Ranks 168 on Exclusive 'Franchise Times' Top 400September 26, 2023 | finance.yahoo.comThe Joint Chiropractic Expands into West VirginiaSeptember 19, 2023 | finance.yahoo.comThe Joint Chiropractic is Named the Official Chiropractor of Fresno State AthleticsSeptember 15, 2023 | markets.businessinsider.comJoint (JYNT) Gets a Hold from Maxim GroupSeptember 14, 2023 | finance.yahoo.comThe Joint (JYNT) Q2 Earnings Miss Estimates, 2023 View DownSeptember 14, 2023 | finance.yahoo.comInsider Buying: Partners Bandera Acquires 47,156 Shares of The Joint Corp (JYNT)September 14, 2023 | msn.comThe Joint Corp. expects an 18% topline jump for Q2September 13, 2023 | marketwatch.comJoint Corp. to Cull About 10% of Owned or Managed ClinicsSeptember 13, 2023 | finance.yahoo.comThe Joint Corp. Reports Preliminary Second Quarter 2023 Financial ResultsSeptember 8, 2023 | benzinga.com572K Reasons To Be Bullish On Joint StockAugust 28, 2023 | msn.comJoint announces receipt of Nasdaq listing delinquency noticeSee More Headlines Receive JYNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2023Today12/03/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Patent owners & lessors Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:JYNT CUSIPN/A CIK1612630 Webwww.thejoint.com Phone(480) 245-5960Fax480-513-7989Employees359Year FoundedN/APrice Target and Rating Average Stock Price Target$21.00 High Stock Price Target$30.00 Low Stock Price Target$13.00 Potential Upside/Downside+126.8%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.13 Trailing P/E Ratio71.24 Forward P/E Ratio77.17 P/E GrowthN/ANet Income$630,000.00 Net Margins1.69% Pretax Margin2.76% Return on Equity5.60% Return on Assets1.99% Debt Debt-to-Equity Ratio0.06 Current Ratio1.03 Quick Ratio1.03 Sales & Book Value Annual Sales$101.91 million Price / Sales1.34 Cash Flow$0.54 per share Price / Cash Flow17.20 Book Value$2.39 per share Price / Book3.87Miscellaneous Outstanding Shares14,750,000Free Float14,164,000Market Cap$136.59 million OptionableNot Optionable Beta1.44 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Peter D. Holt (Age 64)CEO, President & Director Comp: $469.55kJake Singleton (Age 41)Chief Financial Officer Comp: $280.92kMr. Jorge ArmenterosSenior Vice President of OperationsMr. Charles NellesChief Technology OfficerDr. Steven KnaufVice President of Chiropractic & ComplianceMs. Lori I. Abou Habib (Age 43)Chief Marketing Officer Ms. Krischelle TennessenChief Human Resources OfficerMr. Craig P. Colmar J.D. (Age 70)Secretary Comp: $37kMore ExecutivesKey CompetitorsVaxxinityNASDAQ:VAXXI-MabNASDAQ:IMABFONARNASDAQ:FONRSo-Young InternationalNASDAQ:SYJupiter WellnessNASDAQ:JUPWView All CompetitorsInsiders & InstitutionsWalleye Capital LLCSold 81,214 shares on 11/21/2023Ownership: 0.251%First Foundation AdvisorsBought 148,631 shares on 11/16/2023Ownership: 1.007%AQR Capital Management LLCBought 6,526 shares on 11/15/2023Ownership: 0.592%GSA Capital Partners LLPSold 34,053 shares on 11/15/2023Ownership: 0.367%California State Teachers Retirement SystemSold 1,595 shares on 11/14/2023Ownership: 0.021%View All Insider TransactionsView All Institutional Transactions JYNT Stock Analysis - Frequently Asked Questions Should I buy or sell Joint stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares. View JYNT analyst ratings or view top-rated stocks. What is Joint's stock price target for 2024? 4 equities research analysts have issued 12 month target prices for Joint's stock. Their JYNT share price targets range from $13.00 to $30.00. On average, they expect the company's stock price to reach $21.00 in the next year. This suggests a possible upside of 126.8% from the stock's current price. View analysts price targets for JYNT or view top-rated stocks among Wall Street analysts. How have JYNT shares performed in 2023? Joint's stock was trading at $13.98 at the beginning of 2023. Since then, JYNT stock has decreased by 33.8% and is now trading at $9.26. View the best growth stocks for 2023 here. Are investors shorting Joint? Joint saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 700,200 shares, an increase of 18.9% from the October 31st total of 589,100 shares. Based on an average daily trading volume, of 146,400 shares, the days-to-cover ratio is currently 4.8 days. View Joint's Short Interest. When is Joint's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024. View our JYNT earnings forecast. How were Joint's earnings last quarter? The Joint Corp. (NASDAQ:JYNT) issued its earnings results on Thursday, November, 9th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.09. The business had revenue of $29.47 million for the quarter, compared to analysts' expectations of $29.55 million. Joint had a trailing twelve-month return on equity of 5.60% and a net margin of 1.69%. What guidance has Joint issued on next quarter's earnings? Joint updated its FY 2023 earnings guidance on Thursday, November, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $115.00 million-$118.00 million, compared to the consensus revenue estimate of $116.23 million. What is Peter D. Holt's approval rating as Joint's CEO? 87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Joint own? Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), RTX (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE). When did Joint IPO? (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager. Who are Joint's major shareholders? Joint's stock is owned by many different retail and institutional investors. Top institutional shareholders include Skylands Capital LLC (3.40%), First Foundation Advisors (1.01%), Northern Trust Corp (0.87%), Verus Capital Partners LLC (0.73%), O Brien Greene & Co. Inc (0.69%) and AQR Capital Management LLC (0.59%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella. View institutional ownership trends. How do I buy shares of Joint? Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:JYNT) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.